This inventor holds 1 USPTO granted patent. Top assignees: Nume Health, LLC, The Administrators of the Tulane Educational Fund, United States Department of Agriculture. Active years: 2015.
Company Filing History:
1 out of 1 
1 out of 248 
1 out of 3 
Years Active: 2015
Title: Thomas T Y Wang: Innovator in Obesity and Diabetes Treatment
Introduction
Thomas T Y Wang is a notable inventor based in Beltsville, MD (US). He has made significant contributions to the field of medical treatments, particularly in addressing obesity and diabetes. His innovative approaches have the potential to impact many lives positively.
Latest Patents
Wang holds a patent for "Compositions and methods for treating obesity and diabetes." This patent discloses methods of modulating the expression of genes linked to various metabolic processes. These include adipocytokine signaling, carbohydrate metabolism, and insulin signaling. The patent also outlines methods for treating conditions such as hyperlipidemia, obesity, cardiovascular disease, and diabetes. The composition involves administering at least one isolated glyceollin to stimulate glucose uptake in animals in need.
Career Highlights
Throughout his career, Thomas T Y Wang has worked with reputable organizations, including the Administrators of the Tulane Educational Fund and the United States Department of Agriculture. His work in these institutions has allowed him to develop and refine his innovative ideas in the medical field.
Collaborations
Wang has collaborated with notable colleagues, including Matthew E Burow and Stephen M Boue. These partnerships have likely contributed to the advancement of his research and the successful development of his patent.
Conclusion
Thomas T Y Wang is a distinguished inventor whose work in treating obesity and diabetes showcases his commitment to improving health outcomes. His innovative methods and collaborations highlight the importance of research in addressing critical health issues.